Abnormal Tau interactions with mitochondrial proteins have been reported to be causal in mitochondrial dysfunction in Alzheimer's diseases [54]–[57], and abnormal LC3/MAP1b interaction with mitochondria resulted in mitophagy in Parkinson disease models [53]. Here, MAP1B is linked to early-onset autosomal dominant Alzheimer disease.